Floatz logo

8 assets in Monoclonal Gammopathy

Therapeutic assets addressing Monoclonal Gammopathy, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Dexasone
Monoclonal Gammopathy
Hellenic Society of HematologyP3BB (67)
Daratumumab
Monoclonal Gammopathy
Hellenic Society of HematologyP2B (60)
Belantamab Mafodotin
Monoclonal Gammopathy
Hellenic Society of HematologyP1/2CC (47)
Lenalidomide
Monoclonal Gammopathy
Hellenic Society of HematologyP1/2CC (47)
Pomalidomide
Monoclonal Gammopathy
Hellenic Society of HematologyP1/2CC (47)
Nirogacestat
Monoclonal Gammopathy
Hellenic Society of HematologyP1/2CC (45)
Dickkopf-Related Protein 1
Monoclonal Gammopathy
Case Comprehensive Cancer CenterEarly P1C (39)
Florbetaben
Monoclonal Gammopathy
University of ZurichN/AD (30)